Precision Medicine—Are We There Yet? A Narrative Review of Precision Medicine’s Applicability in Primary Care
Journal of Personalized Medicine · 15.04.2024 · 14 (4) · 418
DOI: 10.3390/jpm14040418 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Personalized Medicine, online erschienen am 15.04.2024. Verfasst von William Evans und 3 weiteren Autor:innen. Beteiligte Einrichtung: Primary Care Stratified Medicine (PRISM), Division of Primary Care, University of Nottingham, Nottingham NG7 2RD, UK. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIHR Academy, National Institute for Health Research (NIHR).
Abstract (Originalsprache)
Precision medicine (PM), also termed stratified, individualised, targeted, or personalised medicine, embraces a rapidly expanding area of research, knowledge, and practice. It brings together two emerging health technologies to deliver better individualised care: the many “-omics” arising from increased capacity to understand the human genome and “big data” and data analytics, including artificial intelligence (AI). PM has the potential to transform an individual’s health, moving from population-based disease prevention to more personalised management. There is however a tension between the two, with a real risk that this will exacerbate health inequalities and divert funds and attention from basic healthcare requirements leading to worse health outcomes for many. All areas of medicine should consider how this will affect their practice, with PM now strongly encouraged and supported by government initiatives and research funding. In this review, we discuss examples of PM in current practice and its emerging applications in primary care, such as clinical prediction tools that incorporate genomic markers and pharmacogenomic testing. We look towards potential future applications and consider some key questions for PM, including evidence of its real-world impact, its affordability, the risk of exacerbating health inequalities, and the computational and storage challenges of applying PM technologies at scale.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Primary Care Stratified Medicine (PRISM), Division of Primary Care, University of Nottingham, Nottingham NG7 2RD, UK.
- PHG Foundation, Cambridge University, Cambridge CB1 8RN, UK.
- Dalla Lana School of Public Health, University of Toronto, Toronto, ON M5S 1A8, Canada.
ORCID-Profile: William Evans, Joe Kai, Nadeem Qureshi
Förderung
- NIHR Academy
- National Institute for Health Research (NIHR)
Zitieren
APA
Evans, W., Meslin, E. M., Kai, J., & Qureshi, N. (2024). Precision Medicine—Are We There Yet? A Narrative Review of Precision Medicine’s Applicability in Primary Care. Journal of Personalized Medicine, 14(4), 418. https://doi.org/10.3390/jpm14040418
Vancouver
Evans W, Meslin EM, Kai J, Qureshi N. Precision Medicine—Are We There Yet? A Narrative Review of Precision Medicine’s Applicability in Primary Care. Journal of Personalized Medicine. 2024;14(4):418. doi:10.3390/jpm14040418
BibTeX
@article{Evans2024,
author = {Evans, William and Meslin, Eric M and Kai, Joe and Qureshi, Nadeem},
title = {Precision Medicine—Are We There Yet? A Narrative Review of Precision Medicine’s Applicability in Primary Care},
journal = {Journal of Personalized Medicine},
year = {2024},
volume = {14},
number = {4},
pages = {418},
doi = {10.3390/jpm14040418}
}
EUVIMED